Page 17 - 2020-2021-Heroes-Program-Bklt-v1_fa_Neat

Saul Rosenberg
Saul Rosenberg is Executive Director of Oncology Discovery at AbbVie. He received his B.S. degree
from MIT and his Ph.D. from the University of California at Berkeley in the laboratories of Professor
Henry Rapoport. His current research efforts are focused on the areas of apoptosis, epigenetics
and cell cycle regulation.

Xiaohong Song
Xiaohong Song is a Medicinal Chemist II at AbbVie. He received his M.S. in Medicinal Chemistry
from Jiaotong University, China. Since joining AbbVie, Xiaohong’s research has focused on the
generation of molecules for the treatment of cancer.

Andrew Souers
Andy Souers is a Distinguished Research Fellow at AbbVie. He received his Ph.D. in Chemistry from
UC Berkeley, where he studied under Professor Jonathan Ellman. Since joining AbbVie Oncology,
Andy’s research has focused on the generation of small molecules and empowered biologics with
an emphasis on BCL-2 family inhibitors.

Gerald Sullivan (deceased)
Gerard Sullivan was a Senior Research Scientist at AbbVie. He received his B.S. in Chemistry from
the university of Missouri St. Louis, followed by an extensive and highly accomplished industrial
career. He made critical contributions to venetoclax, consistently energized the chemists around
him, and avidly routed for the Cardinals.

Zhi-Fu Tao
Zhi-Fu Tao is a Principal Research Scientist II at AbbVie. He received his Ph.D. in Organic Chemistry
and postdoctoral training in Biochemistry. Zhi-Fu has played a key role in the discovery of
multiple small molecule and antibody drug conjugate clinical candidates that target the BCL-2
family proteins.

#HeroesofChemistry 17